Musculoskeletal system disorders market overview and analysis by type, treatment and end user- forecast to 2030. According to MRFR analysis, the global musculoskeletal system disorders market is expected to register a CAGR of 6.8% during the forecast period of 2022 to 2030 and value at USD 5,323.53 Million by 2030.
Musculoskeletal system diseases have an effect on the muscles, tendons, ligaments, and other musculoskeletal systems. These disorders are also referred to as “repetitive motion injuries.” Musculoskeletal system disorders can be caused by repeatedly making the same motion or by lifting heavy objects. They primarily affect the neck, upper and lower back, as well as other bodily parts.
Some of the factors driving the growth of the global market for musculoskeletal system diseases include an increase in prevalence, an increase in the elderly population worldwide, the prevalence of poor posture and inadequate fitness levels, as well as higher prevalence. However, it is expected that the high cost of surgery will limit the market’s growth for musculoskeletal system issues globally.
The global musculoskeletal system disorders market is currently dominated by several market players. The key players are involved in product launches and strategic collaborations to strengthen their market positions.
Key Players:
Some of the key players in the global musculoskeletal system disorders market are AB Science (France), AbGenomics International, Inc. (US), Alder BioPharmaceuticals,Inc. (US), Amgen Inc. (US), Lexicon Pharmaceuticals, Inc. (US), LG Chem (South Korea), OrthoTrophix, Inc. (US), Tarsa Therapeutics, Inc. (US), PhytoHealth Corporation (Taiwan), Eisai Co., Ltd (Japan), Astellas Pharma Inc. (Japan), AstraZeneca (UK), Baxter (US), and GlaxoSmithKline PLC (UK).
Segmentation:
The global musculoskeletal system disorders market size has been segmented based on type, treatment, and end user.
The market, based on type, has been divided into rheumatoid arthritis, osteoarthritis, osteoporosis, psoriatic arthritis, ankylosing spondylitis, fibromyalgia, and others. The rheumatoid arthritis segment is likely to be the largest during the review period due to a growing aging population and increasing prevalence of rheumatoid arthritis globally. Around 1.3 million Americans are diagnosed with rheumatoid arthritis every year. The osteoarthritis segment is predicted to be the fastest-growing due to the rising prevalence of the disorder in the elderly.
The global musculoskeletal system disorders market has been segmented, on the basis of treatment, into corticosteroids, biologics, physical therapy, extracorporeal shock wave therapy, protein therapy, synthetic bone graft, composite grafts, demineralized bone matrix, and others. The corticosteroids segment is expected to hold the majority share of the market the drugs help increase muscle strength and quicken the recovery process. The biologics segment is expected to be the fastest-growing due to the increasing use of biologics in the treatment of musculoskeletal system disorders. Biologic therapies include alpha (TNF-α) blockers that help reduce muscle and joint pain. The cost of the treatment is also less as compared to other treatment types.
The end user segments of the market are hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment is expected to hold the largest share of the market as these centers are the primary locations for patients receiving treatment and surgery.
Regional Analysis:
The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of musculoskeletal system disorders and rising per capita healthcare expenditure. The musculoskeletal system disorders market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European musculoskeletal system disorders market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The musculoskeletal system disorders market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing patient pool of musculoskeletal system disorders and rising awareness about the treatment methods, the market in Asia-Pacific is expected to be the fastest-growing. The musculoskeletal system disorders market in the Middle East & Africa has been divided into the Middle East and Africa.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
